Promega corporation:1107424 - ADP-GLO(TM) kinase assay, 10,000 assays - for NIH/ncats staff ajit jadhav
Ended Awarded
- Contract number
- HHSN31900004
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,345
Award facts
- Contract value 100% obligated
- $9,344.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a firm fixed price contract award valued at $9,344.70 from the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, for the procurement of ADP-Glo Kinase Assay kits containing 10,000 assays. The contract was awarded on August 20, 2015, with an ultimate completion date of February 29, 2016, and was executed as a call against Promega's existing $10 million Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations. The contract carried no small business set-aside designation and specified Madison, Wisconsin as the place of performance. The assays procured are intended for use by NCATS staff member Ajit Jadhav in support of the center's translational science research initiatives.
The Kinase Assay kits are specialized biochemical reagents used for drug discovery and development research, enabling researchers to measure kinase enzyme activity—a critical function in understanding cellular signaling pathways and identifying potential therapeutic compounds. NCATS, which focuses on accelerating the translation of laboratory discoveries into clinical applications and medical treatments, frequently requires such advanced research reagents to support its intramural and collaborative research programs. Promega's established relationship with NIH through its BPA vehicle demonstrates the company's capability and reliability in supplying critical scientific consumables to federal research agencies.
Quick answers
Who was awarded contract HHSN31900004?
HHSN31900004 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on August 20, 2015.
How much is contract HHSN31900004 worth?
The government has obligated $9,345 on HHSN31900004.
Is contract HHSN31900004 an order under another contract?
Yes. HHSN31900004 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN31900004 competed?
The extent of competition for HHSN31900004 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award